What is Halda Therapeutics worth?
$3.0Blast known valuation
Halda Therapeutics last raised $126.5M in its Later Stage VC (Series B) (Jul 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Halda Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2024 | Later Stage VC (Series B) | $126.5M | ▮ | ▮ |
| Dec 2021 | Early Stage VC | $41.0M | ▮ | ▮ |
| Feb 2019 | Early Stage VC | $6.3M | ▮ | ▮ |
How Halda Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Halda Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Halda Therapeutics worth?
- Halda Therapeutics's last known valuation is $3.0B.
- How much has Halda Therapeutics raised?
- Halda Therapeutics has raised $227.1M in total funding across 3 recorded rounds.
- When did Halda Therapeutics last raise?
- Halda Therapeutics last raised in Jul 2024 (Later Stage VC (Series B)), raising $126.5M.